Murine Lewis lung carcinoma-derived endothelium expresses markers of endothelial activation and requires tumor-specific extracellular matrix in vitro

Neoplasia

Volumn 5, Issue 3, 2003, Pages 205-217

  Allport, Jennifer R ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adhesion molecule; Endothelium; Extracellular matrix; Murine; Tumor

Indexed keywords

ANTIBODY; BETA CATENIN; CADHERIN; CD31 ANTIGEN; FIBRONECTIN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERCELLULAR ADHESION MOLECULE 2; PADGEM PROTEIN; TUMOR MARKER; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; IN VITRO STUDY; LEWIS CARCINOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 0037902072     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1476-5586(03)80053-2     Document Type: Article

References (38)

1. Gimbrone MA Jr., Cybulsky MI, Kume N, Collins T, and Resnick N (1995). Vascular endothelium: an integrator of pathophysiological stimuli in atherogenesis. Ann NY Acad Sci 748, 122-31.
2. Luscinskas FW, and Gimbrone MA Jr. (1996). Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu Rev Med 47, 413-21.
3. Shepro D, and D'Amore PA (1980). Endothelial cell metabolism. Adv Microcirc 9, 161-205.
4. Garlanda C, and Dejana E (1997). Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol 17, 1193-202.
5. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, and McDonald DM (2000). Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156, 1363-80.
6. Coussens L, Fingleton B, and Matrisian L (2002). Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-92.
7. Tempia-Caliera AA, Horvath LZ, Zimmermann A, Tihanyi TT, Korc M, Friess H, and Buchler MW (2002). Adhesion molecules in human pancreatic cancer. J Surg Oncol 79, 93-100.
8. Numahata K, Satoh M, Handa K, Saito S, Ohyama C, Ito A, Takahashi T, Hoshi S, Orikasa S, and Hakamori SI (2002). Sialosyl-Le(x) expression defines invasive and metastatic properties of bladder carcinoma. Cancer 94, 673-85.
9. Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, Letarte M, Vitetta ES, and Thorpe PE (1995). Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 12, 1623-34.
10. Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Jaffe EA, and Old LJ (1992). Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc Natl Acad Sci 89, 10832-36.
11. Brown EB, Campbell RB, Tsuzuki Y, Xu L, Carmeliet P, Fukumura D, and Jain RK (2001). In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med 7, 864-68.
12. Sckell A, Safabakhsh N, Dellian M, and Jain RK (1998). Primary tumor size-dependent inhibition of angiogenesis at a secondary site: an intravital microscopy study in mice. Cancer Res 58, 5866-69.
13. Hannum RS, Ojeifo JO, Zweibel JA, and McLesky SW (2001). Isolation of tumor-derived endothelial cells. Microvasc Res 61, 287-90.
14. Alessandri G, Chirivi RGS, Fiorentini S, Dossi R, Bonardelli S, Giulini SM, Zanetta G, Landoni F, Graziotti PP, Turano A, Caruso A, Zardi L, Giavazzi R, and Bani MR (1999). Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells. Clin Exp Metastasis 17, 655-62.
15. Langley RR, Tsan RZ, Nelkin G, Shih N, and Fidler IJ (2002). Phenotypic diversity of endothelial cells. Clin Exp Metastasis 19 (Supplement).
16. St. Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, and Kinzler KW (2000). Genes expressed in human tumor endothelium. Science 289, 1197-202.
17. Engvall E, and Ruoslahti E (1977). Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 20, 1-5.
18. Allport JR, Lim Y-C, Shipley JM, Senior RM, Shapiro SD, Matsuyoshi N, Vestweber D, and Luscinskas FW (2002). Neutrophils from MMP-9-or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in vitro, J Leukoc Biol 71, 821-28.
19. Lagasse E, and Weissman IL (1996). Flow cytometric identification of murine neutrophils and monocytes. J Immunol Methods 197, 139-50.
20. Jain RK, Munn LL, and Fukumura D (2000). Dissecting tumour pathophysiology using intravital microscopy, Nat Rev Cancer 2, 266-76.
21. Asahara T, and Isner JM (2002). Endothelial progenitor cells for vascular regeneration. J Hematother Stem Cell Res 11, 171-78.
22. Folkman J (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat Med 1, 27-31.
23. Dias S, Shmelkov SV, Lam G, and Rafii S (2002). VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis induction, Blood 99, 2532-40.
24. Dias S, Choy M, Alitalo K, and Rafii S (2002). Vascular endothelial growth factor (VEGF)-C signaling through Flt-4 (VEGFR-3) mediates leukemic cell proliferation, survival and resistance to chemotherapy. Blood 99, 2179-84.
25. Bochner BS, Luscinskas FW, Gimbrone MA Jr., Newman W, Sterbinsky SA, Derse-Anthony CP, Klunk D, and Schleimer RP (1991). Adhesion of human basophils, eosinophils and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial adhesion molecules. J Exp Med 173, 1553-57.
26. Wijelath ES, Murray J, Rahman S, Patel Y, Ishida A, Strand K, Aziz S, Cardona C, Hammond WP, Savidge GF, Rafii S, and Sobel M (2002). Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 91, 25-31.
27. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, and Isner JM (1999). Bone marrow origin of endothelial progenitor cells responsible for post-natal vasculogenesis in physiological and pathological neovascularization, Circ Res 85, 221-28.
28. Gunsilius E, Duba HC, Petzer AL, Kahler CM, Grunewald K, Stockhammer G, Gabl C, Dirnhofer S, Clausen J, and Gastl G (2000). Evidence from a leukemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 355, 1659-60.
29. Li Y, Wang M-N, Li H, King KD, Bassi R, Sun H, Santiago A, Hooper AT, Bohlen P, and Hicklin DJ (2002). Active immunization against vascular endothelial growth factor receptor flk-1 inhibits tumor angiogenesis and metastasis. J Exp Med 195, 1575-84.
30. Kimura Y, and Okuda H (2001). Resveratol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131, 1844-49.
31. Gimbrone Jr, MA, Bevilacqua MP, and Cybulsky MI (1990). Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis. Ann NY Acad Sci 598, 77-85.
32. Langley RR, Russell J, Eppihimer MJ, Alexander SJ, Gerritsen ME, Specian RD, and Granger DN (1999). Quantification of murine endothelial cell adhesion molecules in solid tumors. Am J Physiol 277, H1156-66.
33. Langley RR, Carlisle R, Ma L, Specian RD, Gerritsen ME, and Granger DN (2001). Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma. Microcirculation 8, 335-45.
34. Rood PM, Dercksen MW, Cazemier H, Kerst JM, Von dem Borne AE, Gerritsen WR, and vanderSchoot CE (2000). E-selectin and very late antigen-4 mediate adhesion of hematopoietic progenitor cells to bone marrow endothelium. Ann Hematol 79, 477-84.
35. Dimitroff CJ, Lee JK, Rafil S, Fuhlbrigge RC, and Sackstein R (2001). CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol 153, 1277-86.
36. Greenberg AW, Kerr WG, and Hammer DA (2000). Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development. Blood 95, 478-86.
37. Dejana E, Corada M, and Lampugnani G (1995). Endothelial cell-to-cell junctions. FASEB J 9, 910-18.
38. Dejana E (1996). Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest 98, 1949-53.